Medexprim combines the ArchiMed platform with its Radiomics Enabler® solution to facilitate the collection and management of imaging data in retrospective and prospective clinical studies.
Medexprim combines the ArchiMed platform with its Radiomics Enabler® solution to facilitate the collection and management of imaging data in retrospective and prospective clinical studies.
Sword Group and Medexprim are partnering in view to offer cancer centers and large hospitals a unified solution to facilitate translational research, combining clinical and imaging data.